Home
Kobo Biotech Ltd Share Price History
Kobo Biotech Ltd
BSE : 21 Apr, 2025
3.10.1 (4.7%)
Prev Close
3.0
Open Price
3.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
4195
Today's High / Low
3.1 / 2.9
52 WK High / Low
5.1 / 2.5
Market Price of Kobo Biotech Ltd
1M
1Y
3Y
5Y
Monitoring Kobo Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 0 |
| Sales YoY Gr. | - |
| Adj EPS | 0 |
| YoY Gr. | - |
| Net Profit (Cr.) | -19 |
| BVPS | -7.8 |
Key Financial Parameters
| Parameter | 2011 |
|---|---|
| Return on Capital Emp. % | 10.76 |
| Op. Profit Mgn % | 17.19 |
| Net Profit Mgn % | 5.75 |
| Debt to Equity % | 2.14 |
Latest Shareholding
Promoters Holdings Over Time
About Kobo Biotech Ltd
- Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
- Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
- The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.
Popular Search
FAQs for Kobo Biotech Ltd Share Price History
What are the key events that typically impact Kobo Biotech Ltd's share price history?
Key events that impact Kobo Biotech Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Kobo Biotech Ltd's share price history?
Stock splits reduce the nominal price of Kobo Biotech Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Kobo Biotech Ltd?
Dividends can influence Kobo Biotech Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Kobo Biotech Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Kobo Biotech Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Kobo Biotech Ltd’s share price history?
To understand Kobo Biotech Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
